To access any content or REGISTER in less than 3 minutes.

RACING Trial: Rethinking LDL-C Lowering in ASCVD

Explore the RACING trial and its subgroup analyses comparing moderate-intensity statin + ezetimibe combination therapy with high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease.

Content exclusive for connected users. Please sign in or register to access more.

Already have an account?

New here?

Create account